Navigate to
-
A roundup of Prime's award-winning presentations and insights at AMCP Nexus in National Harbor, Maryland
PA Sub-Categories: Awards GLP-1 Specialty drugs Prime Article: Stories -
New indications for approved gene / cell therapy products - 2024 Generic Name Brand Name Manufacturer Indication(s) Route of Administration Month Approved* fidanacogene elaparvovec-dzkt Beqvez™...
-
Industry experts share new insights from PBM industry, including GLP-1 weight-loss drugs, biosimilars and rising pharmaceutical costs
Prime Article: Stories -
In the U.S. Food and Drug Administration (FDA)’s latest annual report of drug approvals, the agency shared it approved a total of 46 novel drugs in 2025. Here’s how that stacks up against years...
PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Perspectives -
A roundup of Prime's award-winning presentations and insights at AMCP 2026 in Nashville, Tennessee
-
Managed Healthcare Executive
PA Sub-Categories: GLP-1 Prime Article: In the News -
USA Today
PA Sub-Categories: GLP-1 Prime Article: In the News -
Reuters
PA Sub-Categories: GLP-1 Prime Article: In the News